Kimer Med
Nelson · Founded 2020
About Kimer Med
Kimer Med is developing a family of broad-spectrum antiviral therapeutics. Our first targets are the Dengue virus and pandemic preparedness. We closed our Series A capital raise in Oct 2024.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.7M
- Funding stage: Early Stage Venture
- Last round: Grant (Jul 2024)
- Website: https://kimermed.co.nz
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kimer-med-122402 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.